Skip to main content
Log in

Comparison of acquired cholesteatoma between pediatric and adult patients

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The quantification of angiogenesis and metalloproteinases may be useful in cholesteatoma behavior assessment as markers of its aggressiveness. The objective of this study is to compare markers CD31, MMP2 and MMP9 in pediatric and adult patients. This study is based on cross-sectional studies of pediatric (≤18 years old) and adult groups (≥19 years old). Samples of 120 cholesteatomas were fixed in 10% formol, prepared on five slides of each sample through habitual histological techniques, and number of blood vessels (CD31), marking with MMP2 and MMP9, number of matrix cells and thickness at perimatrix cell were observed. Data were analyzed through SPSS using Spearman and Mann–Whitney coefficients. Cholesteatomas were equally distributed: 60 in pediatric patients (11.77 ± 3.57 years); 60 in adult patients (38.29 ± 14.51 years). When correlating the number of blood vessels and metalloproteinases with perimatrix thickness, we obtained the following values: pediatric CD31, 7 (4–11); adult CD31, 4 (0–10) (P = 0.044); pediatric cytoplasmatic MMP2, 1 (0–3); adult cytoplasmatic MMP2, 0 (0–1) (P = 0.006); pediatric nuclear MMP2, 0 (0–1); adult nuclear MMP2, 0 (0–1) (P = 0.056); pediatric MMP9, 2 (0–4); adult MMP9, 0 (0–4) (P = 0.049). In conclusion, pediatric cholesteatomas present a more exacerbated inflammatory degree, produce more metalloproteinases, factors that, when combined, could characterize pediatric cholesteatomas as more aggressive than adult cholesteatomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Schuknecht HF (1974) The pathology of the ear. Harvard University, Cambridge

    Google Scholar 

  2. Tos M (1988) Incidence, etiology and pathogenesis of cholesteatoma in children: a long-term study of results. Otol Rhinol Laryngol 40:110–117

    CAS  Google Scholar 

  3. Kemppainen HO, Puhakka HJ, Laippala PJ, Sipila MM, Manninen MP, Karma PH (1999) Epidemiology and etiology of middle ear cholesteatoma. Acta Otolaryngol 119:568–572

    Article  PubMed  CAS  Google Scholar 

  4. Quantin L, Fernández SC, Moretti J (2002) Congenital cholesteatoma of external auditory canal. Int J Pediatr Otorhinolaryngol 62:175–179

    Article  PubMed  Google Scholar 

  5. Lim DJ, Saunders WE (1972) Acquired cholesteatoma: light and electron microscopic observations. Ann Otol 81:2–12

    Google Scholar 

  6. Sheehy JL (1978) Management of cholesteatoma in children. Adv Otorhinolaryngol 23:58–64

    PubMed  CAS  Google Scholar 

  7. Tos M (1983) Treatment of cholesteatoma in children: a long-term study of results. J Otol 4:189–197

    CAS  Google Scholar 

  8. Edelstein DR (1989) Acquired cholesteatoma in pediatric age group. Otoloraryngol Clin North Am 22(5):955–964

    CAS  Google Scholar 

  9. Glasscock ME, Dickins JFE, Wiet R (1981) Cholesteatoma in children. Laryngoscope 91:1743–1753

    PubMed  Google Scholar 

  10. Ruah CB, Schachem PA, Paparella MM, Zelterman D (1992) Mechanisms of retraction pocket formation in the pediatric tympanic membrane. Arch Otolaryngol Head Neck Surg 118(12):1298–1305

    PubMed  CAS  Google Scholar 

  11. Bujia J, Holly A, Antoli-Candela F, Tapia MG (1996) Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1. Laryngoscope 106(7):865–868

    Article  PubMed  CAS  Google Scholar 

  12. Palva A, Karma P, Kärjä J (1997) Cholesteatoma in children. Arch Otolaryngol 103(2):74–77

    Google Scholar 

  13. Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A et al (2000) Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 21:793–798

    PubMed  CAS  Google Scholar 

  14. Smythe JL, Brachman D, Grahm M (1984) Complications of cholesteatoma: a report on 1024 cases. In: Swartz JD (ed) Cholesteatomas of the middle ear. Diagnosis, etiology and complications. Radiol Clin North Am 22:15–34

  15. Quaranta A, Resta L, Santangelo A (1986) Otomastoid cholesteatoma in children: histopathological findings. Int J Pediatric Otorhinolaryngol 12(2):121–126

    Article  CAS  Google Scholar 

  16. Dornelles CD (2004) Colesteatomas Adquiridos: Análise Comparativa da Perimatriz entre Pacientes Pediátricos e Adultos [dissertação]. Porto Alegre, UFRGS

  17. Dornelles CD, Costa SS, Meurer L, Schweiger C (2005) Comparação da espessura da perimatriz, de colesteatomas adquiridos, entre pacientes pediátricos e adultos. Rev Bras ORL 71(6):792–797

    Google Scholar 

  18. Dornelles CD, Costa SS, Meurer L, Schweiger C (2006) Descrição histológica de colesteatomas adquiridos: comparação entre amostras de crianças e de adultos. Rev Bras ORL 72(5):641–648

    Google Scholar 

  19. Milewski C (1998) Role of perimatrix fibroblast in development of acquire middle ear cholesteatoma. A hypothesis. HNO 46(5):494–501

    Article  PubMed  CAS  Google Scholar 

  20. Baak JPA (1991) Manual of quantitative pathology in cancer diagnosis and prognosis. Springer, New York

    Google Scholar 

  21. Meurer L (2003) Densidade microvascular e expressão imunoistoquímica de p21: associação com sobrevida em pacientes submetidos à cirurgia por carcinoma epidermóide de esôfago [tese]. Porto Alegre, UFRGS

  22. Folkman J (1995) Tumor angiogenesis. In: Mendelson JHP, Israel MA, Liotta LA (eds) The molecular basis of cancer. WB Saunders, Philadelphia, pp 206–232

    Google Scholar 

  23. Bernal-Sprekelsen M, Ebmeyer J, Anonopoulos A, Borkowiski G, Sudhoff H (2001) Alteraciones de la membrana basal en el colesteatoma de oído medio. Acta Otorrinolaringol Esp 52(4):330–335

    PubMed  CAS  Google Scholar 

  24. Wilmoth JG, Schultz GS, Antonelli PJ (2003) Tympanic membrane metalloproteinase inflammatory response. Otolaryngol Head Neck Surg 129(6):647–654

    Article  PubMed  Google Scholar 

  25. Medina C, Radomski MW (2006) Role of matrix metalloproteinases in intestinal inflammation. J Pharmacol Exp Ther 318(3):933–938

    Article  PubMed  CAS  Google Scholar 

  26. Banerjee AR, James R, Narula AA (1998) Matrix metalloproteinase-2 and matrix metalloproteinase-9 in cholesteatoma and deep meatal skin. Clin Otolaryngol 23(4):345–347

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank the Pathology and Ear, Nose and Throat Departments of the Hospital de Clínicas de Porto Alegre, for the permission to use their facilities and enable the development of this project. The Research and Post Graduation Group of the Hospital de Clínicas de Porto Alegre (GPPG-HCPA) and the Post Graduation Program in Medical Sciences: Pediatrics Department of the Universidade Federal do Rio Grande do Sul, for their technical support. The Fundo de Incentivo à Pesquisa e Eventos of the Hospital de Clínicas de Porto Alegre (FIPE-HCPA), for the research financing.

Conflict of interest statement

The authors did not have a financial relationship with the organization that sponsored the research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristina de Carvalho Dornelles.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Carvalho Dornelles, C., da Costa, S.S., Meurer, L. et al. Comparison of acquired cholesteatoma between pediatric and adult patients. Eur Arch Otorhinolaryngol 266, 1553–1561 (2009). https://doi.org/10.1007/s00405-009-0957-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-009-0957-0

Keywords

Navigation